FDA Inspection
Morton Drug Company dba Morton LTCMorton Drug Company dba Morton LTC – FDA Inspection, Aug 31, 2018
Record Details
This FDA Inspection record concerns Morton Drug Company dba Morton LTC, with an inspection on August 31, 2018, issued by the Minneapolis District Office, covering human drugs.
View Company Profile
ID · de1f6174-a9ad-4932-b188-d0972242745c
Inspection Facts
- Inspection number
- 1064518
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
2- FDCA 501(a)(2)(A)Beta-lactam drugs, inadequate sanitation
- FDCA 501(a)(2)(A)Disinfecting materials, aseptic processing area
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Morton Drug Company dba Morton LTC
2| Date | Classification | Office | Project area |
|---|---|---|---|
| December 22, 2015 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 20, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Morton Drug Company dba Morton LTC
- FDA Inspection 953460 - 2015-12-22
- FDA Inspection 724709 - 2011-05-20
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.